Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Polytar scalp shampoo returns after four-year absence

Polytar scalp shampoo is now available for pharmacists to order again after four years away from the shelves, manufacturer GlaxoSmithKline has announced.

The medicated shampoo, which contains coal tar solution, returned to pharmacies in June, after GSK received “many communications” about the product.

GSK brand manager Lisa Goodman said making Polytar available again was “an absolute must”, despite past supply issues.

“The Polytar brand helped many people and we’re sure its return, with the launch of Polytar Scalp Shampoo, will be welcomed by previous users,” Ms Goodman said.

GSK predicts there are 1.3 million people with psoriasis in the UK. Polytar’s antibacterial and anti-inflammatory solution helps the treatment of scaling scalp disorders, including psoriasis and dandruff.

Polytar retails at at £5.49 for a 150ml bottle.

To order contact 0800 783 8881

Are you pleased to see Polytar's return?

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008272

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel